BAX logo

Baxter International (BAX)

Profile

Full Name

Baxter International Inc.

Ticker Symbol

BAX

Exchange

NYSE

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

United States

IPO

October 27, 1981

Indexes

S&P 500

Website

http://www.baxter.com

Employees

38000

Key Details

Price

$30.62(-2.36%)

Market cap

Last Dividend

$0.17

TTM Dividend yield

2.61%

Annual revenue

$10.64B(+2.66% YoY)

Annual EPS

-$1.27(-124.28% YoY)

PE ratio

-

Next earnings date

Aug 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $30.62
    BAX price is $30.62

    30-Day Relative Volume

    0.83
    BAX 30-day relative volume is 0.83

    Price Performance

    Price Most recent change

    -2.36%
    BAX price was down -2.36% on Jun 13, 2025

    Price YTD change

    +5.01%
    BAX price is up +5.01% since January 1st

    Price 1-year change

    -9.25%
    BAX price is down -9.25% year-on-year

    Price 3-year change

    -57.22%
    BAX price is down -57.22% over the past 3 years

    Price Range

    Price All-time high

    $95.19
    BAX price is currently -67.83% below its historical high of $95.19

    Price 3-year low

    $26.25
    BAX price is currently +16.65% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $15.71B
    BAX market capitalization is $15.71 billion

    Market cap 3-year change

    -56.4%
    BAX market capitalization is down -56.4% over the past 3 years

    Market cap All-time high

    $47.86B
    BAX market capitalization is currently -67.17% below its historical high of $47.86 billion

    Market cap sector rank

    94.73%
    BAX market capitalization is higher than 94.73% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.71%
    BAX shares outstanding is up +0.71% year-on-year

    Shares Outstanding 3-Year Change

    +1.92%
    BAX shares outstanding is up +1.92% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.74
    BAX beta is 0.74

    200-day SMA

    $33.12
    BAX price is currently -7.55% below its 200-day simple moving average

    50-day SMA

    $30.19
    BAX price is currently +1.43% above its 50-day simple moving average

    RSI

    49.15
    BAX 14-day relative strength index is 49.15

    Volume

    0.83
    BAX 30-day relative volume is 0.83

    ATR

    $0.82
    BAX average true range is $0.82

    10-day Historical Volatility

    29.93%
    BAX 10-day historical volatility is 29.93%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $0.17
    BAX last dividend was $0.17 per share, with an ex-dividend date of May 30, 2025

    Next Dividend

    -
    BAX next dividend has not yet been announced

    Dividend per share

    Dividend per share

    $1.04
    BAX annual dividend per share is $1.04

    Dividend per share Sector Rank

    41.18%
    BAX annual dividend per share is higher than 41.18% of companies in Healthcare sector

    Dividend per share 1-Year Change

    -10.34%
    BAX annual dividend per share is down -10.34% year-on-year

    Dividend per share 3-Year Change

    -4.15%
    BAX annual dividend per share is down -4.15% over the past 3 years

    Dividend yield

    Dividend yield

    3.40%
    BAX annual dividend yield is 3.40%

    Dividend yield Sector Rank

    71.43%
    BAX annual dividend yield is higher than 71.43% of companies in Healthcare sector

    Other

    Payout ratio

    -90.91%
    BAX annual payout ratio is -90.91%

    Dividends paid

    $590.00M
    BAX annual dividends paid is $590.00 million

    Free cash flow

    $559.00M
    BAX annual free cash flow is $559.00 million

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $10.64B
    BAX annual revenue is $10.64 billion

    Revenue Analysts estimate

    $11.38B
    BAX annual revenue is currently -6.52% lower than the consensus analysts' forecast

    Revenue 1-year change

    +2.66%
    BAX annual revenue is up +2.66% year-on-year

    Revenue Sector rank

    94.32%
    BAX annual revenue is higher than 94.32% of companies in Healthcare sector

    EPS

    EPS

    -$1.27
    BAX annual earnings per share is -$1.27

    EPS Analysts estimate

    $2.51
    BAX annual earnings per share is currently -150.53% lower than the consensus analysts' forecast

    EPS 1-year change

    -124.28%
    BAX annual earnings per share is down -124.28% year-on-year

    EPS Sector rank

    50.12%
    BAX annual earnings per share is higher than 50.12% of companies in Healthcare sector

    Profit

    Gross profit

    $3.98B
    BAX annual gross profit is $3.98 billion

    Gross margin

    37.46%
    BAX annual gross profit margin is 37.46%

    Operating profit

    $439.00M
    BAX annual operating income is $439.00 million

    Operating margin

    4.13%
    BAX annual operating profit margin is 4.13%

    Net income

    -$649.00M
    BAX annual net profit is -$649.00 million

    Net margin

    -6.10%
    BAX annual net profit margin is -6.10%

    Expenses

    Total expenses

    $10.20B
    BAX annual total expenses is $10.20 billion

    Operating expenses

    $3.54B
    BAX annual total operating expenses is $3.54 billion

    Cost of goods sold

    $6.65B
    BAX annual cost of goods sold is $6.65 billion

    Selling, general & administrative expenses

    $2.97B
    BAX annual SGA is $2.97 billion

    Depreciation and amortization

    $997.00M
    BAX annual depreciation & amortization is $997.00 million

    Interest expense

    $408.00M
    BAX annual interest expense is $408.00 million

    Income tax

    $37.00M
    BAX annual income tax is $37.00 million

    EBIT & EBITDA

    EBIT

    $52.00M
    BAX annual earnings before interest & taxes is $52.00 million

    EBITDA

    $52.00M
    BAX annual EBITDA is $52.00 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $25.78B
    BAX annual total assets is $25.78 billion

    Non current assets

    $16.93B
    BAX annual long term assets is $16.93 billion

    Current assets

    $8.85B
    BAX annual total current assets is $8.85 billion

    Cash and cash equivalents

    $1.76B
    BAX annual cash & cash equivalents is $1.76 billion

    Accounts receivable

    $1.68B
    BAX annual accounts receivable is $1.68 billion

    Inventory

    $2.05B
    BAX annual inventory is $2.05 billion

    Liabilities

    Total liabilities

    $18.76B
    BAX annual total liabilities is $18.76 billion

    Long term liabilities

    $12.25B
    BAX annual total long term liabilities is $12.25 billion

    Current liabilities

    $6.51B
    BAX annual total current liabilities is $6.51 billion

    Accounts payable

    $968.00M
    BAX annual accounts payable is $968.00 million

    Debt

    Total debt

    $13.45B
    BAX annual total debt is $13.45 billion

    Total debt 1-year change

    -4.7%
    BAX annual total debt is down -4.7% year-on-year

    Long term debt

    $10.62B
    BAX annual long term debt is $10.62 billion

    Short term debt

    $2.83B
    BAX annual short term debt is $2.83 billion

    Equity & Capital

    Shareholders equity

    $6.96B
    BAX annual stockholders equity is $6.96 billion

    Book value

    $6.96B
    BAX annual book value is $6.96 billion

    Retained earnings

    $14.93B
    BAX annual retained earnings is $14.93 billion

    Working capital

    $2.34B
    BAX annual working capital is $2.34 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $1.02B
    BAX annual cash flow from operations is $1.02 billion

    Cash from operations 1-year change

    -40.96%
    BAX annual cash flow from operations is down -40.96% year-on-year

    Cash from investing

    -$626.00M
    BAX annual cash flow from investing activities is -$626.00 million

    Cash from investing 1-year change

    -119.48%
    BAX annual cash flow from investing activities is down -119.48% year-on-year

    Cash from financing

    -$1.08B
    BAX annual cash flow from financing activities is -$1.08 billion

    Cash from financing 1-year change

    +69.02%
    BAX annual cash flow from financing activities is up +69.02% year-on-year

    CAPEX

    CAPEX

    $460.00M
    BAX annual capital expenditures is $460.00 million

    CAPEX 1-year change

    +5.5%
    BAX annual capital expenditures is up +5.5% year-on-year

    Free Cash Flow

    Free cash flow

    $559.00M
    BAX annual free cash flow is $559.00 million

    Free cash flow 1-year change

    -56.67%
    BAX annual free cash flow is down -56.67% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    37.46%
    BAX annual gross profit margin is 37.46%

    Operating margin

    4.13%
    BAX annual operating profit margin is 4.13%

    Net margin

    -6.10%
    BAX annual net profit margin is -6.10%

    ROA & ROE

    ROA

    -2.40%
    BAX annual return on assets is -2.40%

    ROE

    -8.38%
    BAX annual return on equity is -8.38%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    BAX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    BAX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    2.22
    BAX price to book ratio is 2.22

    PB ratio Sector rank

    61.09%
    BAX price to book ratio is higher than 61.09% of companies in Healthcare sector

    PS Ratio

    PS ratio

    1.32
    BAX price to sales ratio is 1.32

    PS ratio Sector rank

    30.72%
    BAX price to sales ratio is higher than 30.72% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $23.73B
    BAX enterprise value is $23.73 billion

    Enterprise value Sector rank

    95.19%
    BAX enterprise value is higher than 95.19% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    74.38
    BAX EV/EBITDA is 74.38

    EV/EBITDA Sector rank

    98.34%
    BAX EV/EBITDA is higher than 98.34% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.36
    BAX annual current ratio is 1.36

    Quick ratio

    1.05
    BAX annual quick ratio is 1.05

    Leverage

    Debt to equity

    1.88
    BAX annual debt to equity ratio is 1.88

    Interest coverage ratio

    0.13
    BAX annual interest coverage ratio is 0.13

    Risk & Stability

    Piotroski F-Score

    5
    BAX piotroski f-score is 5

    Altman Z-Score

    1.84
    BAX altman z-score is 1.84

    Analyst ratings

    Recent major analysts updates

    May 5, 25 Morgan Stanley
    Underweight
    May 2, 25 Wells Fargo
    Equal-Weight
    Mar 10, 25 Barclays
    Overweight
    Feb 21, 25 JP Morgan
    Neutral
    Dec 11, 24 Citigroup
    Neutral
    Nov 11, 24 Stifel
    Buy
    Oct 1, 24 Citigroup
    Neutral
    Aug 8, 24 Goldman Sachs
    Neutral
    Aug 7, 24 Wells Fargo
    Equal-Weight
    Aug 7, 24 JP Morgan
    Neutral

    Institutional Ownership

    Screeners with BAX included

    Growing Shares Outstanding
    US stocks
    S&P 500 companies earnings calendar
    Stocks below SMA 200
    Stocks recommended to hold
    S&P 500 companies
    Stocks below analysts price target
    S&P 500 companies dividend calendar
    Healthcare sector
    All stocks
    • What is the ticker symbol for Baxter International?
    • Does Baxter International pay dividends?
    • What sector is Baxter International in?
    • What industry is Baxter International in?
    • What country is Baxter International based in?
    • When did Baxter International go public?
    • Is Baxter International in the S&P 500?
    • Is Baxter International in the NASDAQ 100?
    • Is Baxter International in the Dow Jones?
    • When was Baxter International's last earnings report?
    • When does Baxter International report earnings?
    • Should I buy Baxter International stock now?

    What is the ticker symbol for Baxter International?

    The ticker symbol for Baxter International is NYSE:BAX

    Does Baxter International pay dividends?

    Yes, Baxter International pays dividends. The last payment was $0.17, with an ex-dividend date on May 30, 2025

    What sector is Baxter International in?

    Baxter International is in the Healthcare sector

    What industry is Baxter International in?

    Baxter International is in the Medical Instruments & Supplies industry

    What country is Baxter International based in?

    Baxter International is headquartered in United States

    When did Baxter International go public?

    Baxter International's initial public offering (IPO) was on October 27, 1981

    Is Baxter International in the S&P 500?

    Yes, Baxter International is included in the S&P 500 index

    Is Baxter International in the NASDAQ 100?

    No, Baxter International is not included in the NASDAQ 100 index

    Is Baxter International in the Dow Jones?

    No, Baxter International is not included in the Dow Jones index

    When was Baxter International's last earnings report?

    Baxter International's most recent earnings report was on May 1, 2025

    When does Baxter International report earnings?

    The next expected earnings date for Baxter International is Aug 6, 2025

    Should I buy Baxter International stock now?

    As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page